Physician profile
John M Lasala
NPI 1982648317
$936,113.13
in general payments reported to CMS, 2019-2025
30 companies · $123K in 2025
The $123K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165K · 2020: $87K · 2021: $98K · 2022: $199K · 2023: $93K · 2024: $171K · 2025: $123K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $113K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $113K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $76K · Travel and Lodging: $42K · Honoraria: $28K · Food and Beverage: $16K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $113,133.75 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $112,587.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $75,620.00 |
| Travel and Lodging | $41,528.82 |
| Honoraria | $28,400.00 |
| Food and Beverage | $15,602.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $219,397.79 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $187,859.56 | 2019-2025 | Amplatzer Talisman, Amplatzer Piccolo, Amplatzer |
| Boston Scientific Corporation | $174,389.86 | 2019-2025 | General - Vascular Access, Versacross Access Solution, Sentinel |
| W. L. Gore & Associates, INC. | $135,154.28 | 2019-2025 | Gore Cardioform Asd Occluder, Gore Cardioform Septal Occluder, Product In Development |
| Abiomed | $97,155.47 | 2019-2025 | Impella |
| Edwards Lifesciences Corporation | $31,275.70 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia, Pascal |
| Chiesi USA, INC. | $23,920.54 | 2019-2020 | |
| Cordis US Corp. | $17,789.64 | 2022-2025 | Selution Slr Pta, Mynx Control, Selution Slr Ptca |
| Biotronik INC. | $13,973.46 | 2019-2025 | Orsiro Mission, Recross |
| Astrazeneca Pharmaceuticals Lp | $11,977.74 | 2019 | |
| Medical Device Business Services, INC. | $10,100.00 | 2020-2021 | |
| Philips North America LLC | $3,196.48 | 2019-2025 | Coronary Other, Eagle Eye |
| Zoll Circulation INC | $3,073.39 | 2021-2024 | Catheter, Downstream Cartridge, Therox Ds2 Console |
| Cardinal Health 200 LLC | $2,565.73 | 2019-2021 | |
| Cardiovascular Systems INC. | $866.52 | 2019-2023 | Diamondback Coronary |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $700.82 | 2021-2025 | Onyx Frontier, Symplicity G3, Corevalve Evolut R |
| Siemens Medical Solutions USA, INC. | $693.61 | 2019-2022 | |
| Penumbra, INC. | $653.19 | 2019-2025 | Indigo System |
| Medtronic Vascular, INC. | $319.40 | 2019-2020 | |
| Teleflex LLC | $286.90 | 2021-2025 | Orsiro Mission, Guideliner |
| Cook Medical LLC | $223.43 | 2019-2022 | |
| Reflow Medical INC | $140.50 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.59 | 2019-2022 | |
| Biosense Webster, INC. | $95.00 | 2019 | |
| Amgen INC. | $73.61 | 2025 | Repatha |
| Z-Medica, LLC | $41.47 | 2019 | |
| Recor Medical INC | $40.74 | 2025 | Paradise Ultrasound Renal Denervation System |
| Portola Pharmaceuticals, LLC | $19.56 | 2020 | |
| Ge Healthcare | $17.08 | 2021 | |
| Merck Sharp & Dohme LLC | $12.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lasala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.